DIRS.INFO The most relevant business & tech news

☆ Jim Cramer: Abbott stock is 'dirt cheap' after a surprising legal win validates our conviction
▼ + stars: | 2024-11-01 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +5 min

The legal overhang on Abbott Labs has been real, even if shares have found some traction in recent months. Bottom line Abbott Labs still faces other cases over its specialized formulas across the country, but Thursday night's win is significant. Abbott shares traded around 22 times forward earnings estimates Friday, below their five-year average of 24, according to FactSet. With victory in hand, Abbott Labs will now begin the next phase of its legal fight on much stronger ground. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

Persons: Mead Johnson, Benckiser, Louis Children's, Abbott, Mead, —, Scott Stoffel, ABT, — Mead Johnson, Jim Cramer, Cramer, Jim Cramer's, Jim, Stacey Wescott Organizations: Abbott Laboratories, Club, Abbott Labs, NEC, CNBC, Abbott, and Drug Administration, Centers for Disease Control, National Institutes of Health, FDA, CDC, NIH, Chicago Tribune, Tribune, Service, Getty Locations: Missouri, St

☆ The current market is 'directionless,' one CIO says, naming 6 stocks he likes right now
▼ + stars: | 2024-09-12 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +4 min

Defensive and dividend plays Alexander's strategy in playing the market right now is through defensive sectors and dividend players. As for dividend plays, Alexander is bullish on the utilities and telco sectors amid falling Treasury yields . Big pharma plays Alexander is also likes health-care and biotech players, especially big pharmaceutical companies producing products serving medical needs. Names he likes include AbbVie , AstraZeneca , Novartis and Johnson & Johnson . Johnson & Johnson, meanwhile, has been building out a "pipeline of drugs," Alexander added.

Persons: Ted Alexander, we've, we're, Alexander, it's, bullish, Durex, They've, Mead Johnson, Johnson Organizations: U.S, U.S . Federal, Sydney, Telecommunications, AT, Verizon, Frontier Communications, London Stock Exchange, Big pharma, AstraZeneca, Novartis, Johnson Locations: U.S ., South Dallas, U.S

☆ Ford shares surge on Tesla's EV price cuts as the legacy automaker falls back on its roots
▼ + stars: | 2024-04-22 | by ( Jeff Marks | ) www.cnbc.com time to read: +4 min

Strong bounce: The S & P 500 was on pace Monday afternoon to break a streak of six down days in a row. (The S & P 500 fell 3% last week.) Ford rallies: Ford was our best-performing portfolio stock Monday and one of the top-performing stocks in all of the S & P 500. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Financials, Wells Fargo, Wells, Ford, Tesla, Jim Farley, Farley, Abbott, Watson, Mead Johnson, Reckitt Benckiser, Johnson, Lockheed Martin, Sherwin Williams, We're, Jim Cramer's, Jim Organizations: CNBC, Nasdaq, Ford, Abbott Laboratories, NEC Society, Abbott, Johnson, SAP, Cadence Design Systems, Nvidia, Danaher, Motors, UPS, GE, PepsiCo, RTX Corp, Lockheed, Treasury, Jim Cramer's Charitable Locations: Wells, Cleveland, Nucor, Freeport, McMoRan

☆ Eli Lilly climbs on win for rival weight-loss drug, and we still feel good about Abbott Labs
▼ + stars: | 2024-03-28 | by ( Jeff Marks | ) www.cnbc.com time to read: +4 min

Abbott update : Shares of Abbott Laboratories were slightly higher Thursday, on pace for their third straight day of gains. The embattled cosmetics company was the top-performing Club stock in Thursday's session, boosted by an upgrade at Bank of America . As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Eli Lilly, Wegovy, Abbott, Louis, Jim, Reckitt's Mead Johnson, Mead, Johnson, Stanley Black, Decker, Estee Lauder, Lauder, there's, Jim Cramer's, AJ Mast Organizations: CNBC, Stocks, Bloomberg, Amazon Pharmacy, Rite, Abbott Laboratories, Abbott, NEC, Home, U.S, Bank of America, Jim Cramer's Charitable, Getty Locations: U.S, St, Illinois, China, Indianapolis , Indiana

☆ US FDA warns 3 baby formula makers to correct manufacturing process controls
▼ + stars: | 2023-08-30 | by ( ) www.reuters.com time to read: +2 min

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. The FDA pulled up these companies for failing to establish processes to ensure infant formula does not become contaminated during manufacturing. The recalls were meant to remove products potentially contaminated with the bacteria cronobacter sakazakii, the FDA added. "The agency... believes that the recalls were effective in removing the potentially contaminated batches of product from the market," the FDA said. Infant formula manufacturing is under greater scrutiny following the shortage of the product last year due to a shutdown of Abbott Laboratories' (ABT.N) unit in Michigan.

Persons: Andrew Kelly, Benckiser, Mead Johnson, Perrigo, ByHeart, Leroy Leo, Krishna Chandra Organizations: Food and Drug Administration, FDA, REUTERS, U.S . Food, Drug Administration, ByHeart Inc, Mead Johnson Nutrition, Abbott Laboratories, Thomson Locations: White Oak , Maryland, U.S, PRGO.N, Wisconsin, Michigan, Bengaluru

☆ Reckitt CEO switch may boost odds of a takeover
▼ + stars: | 2023-04-26 | by ( ) www.reuters.com time to read: +2 min

LONDON, April 26 (Reuters Breakingviews) - Reckitt Benckiser’s (RKT.L) decision to appoint an insider as CEO may help to entice prospective buyers, like U.S. giant Procter & Gamble (PG.N). Reckitt has been a perennial takeover target, as previous bosses struggled to deliver consistently strong revenue growth. It is still paying down a hefty debt pile following an ill-advised $17 billion takeover of baby food maker Mead Johnson in 2017. Net revenue grew by nearly 8% year-on-year in the first quarter – after excluding acquisitions, disposals and currency fluctuations. Reckitt’s shares trade at 17 times forecast 2023 earnings, compared with P&G’s multiple of nearly 25 times.

CNBC: You were the first Hispanic woman to serve on one of the top five Fortune 100 corporate boards, but as of 2022, corporate boards continue to remain majority white and male. What do you see as the biggest obstacle to diversifying corporate boards? Ford director Kimberly Casiano was the first Hispanic woman to serve on a Fortune 100 top five corporate board. I also believe entrepreneurs, who have much more limited resources and leverage than major corporations, are better at compromise and subtle persuasion. Casiano: It is important to remember that gender diversity on corporate boards came years before ethnic diversity started to show its head.

[1/3] Mead Johnson's product Enfamil baby formula are displayed on a store shelf in New York City, U.S., February 10, 2017. Panicked parents had earlier this year emptied the baby formula aisles at supermarkets after former top U.S. manufacturer Abbott Laboratories (ABT.N) in February recalled dozens of types of its Similac, Alimentum and EleCare formulas. Since the Abbott recall, share of Reckitt in the infant formula market has skyrocketed, making it the No.1 supplier in the United States. Companies normally bid for state contracts to be the sole provider of baby formula for low-income families under the Women, Infants and Children (WIC) programme. Reckitt has said its formula factories are operating 24/7, and it was feeding more than 40% of all low-income WIC infants.

Search resuls for: "Mead Johnson"

8 mentions found